December 3, 2020 | Jen Temple, Head of Communications | Reading Time: < 1 minute
Canexia Health’s Co-Founder and Chief Medical Officer David Hunstman was recently interviewed by OncLive as part of their OncLive On Air Podcast. OncLive is a digital platform that offers resources and information to oncology professionals that they can use to help provide the best patient care.
In this exclusive interview, Dr. Huntsman discusses the elements of precision medicine that have contributed to its growth in oncology, some of the setbacks regarding its integration, and areas of research that have the potential to propel precision medicine to the next tier of scientific discovery and application.
October 14, 2021
The FDA is now approving biomarker-informed therapies on a routine basis, yet there is significant disparity in patient access to molecular profiling that would match cancer patients to these targeted treatments.
